|
End-of-day quote
Shenzhen S.E.
01/09/2026
|
5-day change | 1st Jan Change | ||
| 6.120 CNY | +2.34% |
|
-3.92% | -16.96% |
| 25/08 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| Market Cap | 628.74Cr 94Cr 81Cr 76Cr 69Cr 130.03Cr 8.88TCr 130.74Cr 897.3Cr 349.25Cr 4.52TCr 351.21Cr 343.59Cr 15TCr | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 514.61Cr 77Cr 66Cr 62Cr 57Cr 106.43Cr 7.27TCr 107Cr 734.42Cr 285.85Cr 3.7TCr 287.45Cr 281.22Cr 12TCr | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +2.34% | ||
| 1 week | -3.92% | ||
| Current month | +2.34% | ||
| 1 month | +8.90% | ||
| 3 months | +4.08% | ||
| 6 months | -5.26% | ||
| Current year | -16.96% |
| 1 week | 5.89 |  | 6.75 |
| 1 month | 5.53 | | 7.08 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 3,40,000 | 0.0399% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 66Cr 9.83Cr 8.48Cr 7.97Cr 7.26Cr 14Cr 932.51Cr 14Cr 94Cr 37Cr 474.35Cr 37Cr 36Cr 1.57TCr | 62Cr 9.28Cr 8Cr 7.53Cr 6.86Cr 13Cr 880.59Cr 13Cr 89Cr 35Cr 447.94Cr 35Cr 34Cr 1.49TCr |
| Net income | -7.41Cr -1.1Cr -95.05L -89.41L -81.46L -1.53Cr -104.58Cr -1.54Cr -11Cr -4.11Cr -53Cr -4.14Cr -4.05Cr -176.4Cr | -35Cr -5.17Cr -4.46Cr -4.19Cr -3.82Cr -7.18Cr -490.24Cr -7.22Cr -50Cr -19Cr -249.38Cr -19Cr -19Cr -826.89Cr |
| Net Debt | -198.23Cr -29Cr -25Cr -24Cr -22Cr -41Cr -2.8TCr -41Cr -282.9Cr -110.11Cr -1.42TCr -110.73Cr -108.33Cr -4.72TCr | -114.13Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.61TCr -24Cr -162.88Cr -63Cr -819.77Cr -64Cr -62Cr -2.72TCr |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | CN¥6.120 | +2.34% | 4,06,09,710 |
| 31/26/31 | CN¥5.980 | -4.78% | 5,42,17,859 |
| 28/26/28 | CN¥6.280 | -4.27% | 5,50,13,161 |
| 27/26/27 | CN¥6.560 | +4.46% | 9,42,89,038 |
| 26/26/26 | CN¥6.280 | -1.41% | 9,89,53,018 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
